We are live on ! Find out more
DOVA

Dova Pharmaceuticals, Inc. Common Stock
DOVA

Delisted

DOVA was delisted on the 11th of November, 2019.

Back to rankings

48 hedge funds and large institutions have $209M invested in Dova Pharmaceuticals, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 6

113% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 8

30% more capital invested

Capital invested by funds: $160M → $209M (+$48.4M)

23% more funds holding

Funds holding: 39 → 48 (+9)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
48
Holders Change
+9
Holders Change %
+23.08%
% of All Funds
1.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
17
Reduced
6
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$9.55M
2
Morgan Stanley
Morgan Stanley
New York
+$5.58M
3
PA
Perceptive Advisors
New York
+$1.51M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.24M
5
PC
Pier Capital
Connecticut
+$1.19M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.26M
2
SFM
Sphera Funds Management
Israel
-$1.9M
3
Norges Bank
Norges Bank
Norway
-$425K
4
Barclays
Barclays
United Kingdom
-$336K
5
Millennium Management
Millennium Management
New York
-$247K
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$233K -$5.84K -213 -3%
TCIM
27
TIAA CREF Investment Management
New York
$224K -$16.9K -618 -7%
Commonwealth Equity Services
28
Commonwealth Equity Services
Massachusetts
$204K +$195K +7,100 New
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$170K +$123K +4,500 +321%
Manulife (Manufacturers Life Insurance)
30
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$137K +$114K +4,163 +702%
Bank of America
31
Bank of America
North Carolina
$131K +$118K +4,314 +1,798%
AIG
32
American International Group
New York
$100K +$1.75K +64 +2%
JP Morgan Chase
33
JP Morgan Chase
New York
$62K +$58.9K +2,150 New
SO
34
STRS Ohio
Ohio
$43K – – –
Citigroup
35
Citigroup
New York
$41K +$39.1K +1,428 New
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
$33.8K +$32.2K +1,175 New
Barclays
37
Barclays
United Kingdom
$32K -$336K -12,246 -92%
Macquarie Group
38
Macquarie Group
Australia
$32K +$30.1K +1,100 New
Legal & General Group
39
Legal & General Group
United Kingdom
$27K +$8.22K +300 +46%
Parallax Volatility Advisers
40
Parallax Volatility Advisers
California
$22K +$20.7K +756 New
AWM
41
Avior Wealth Management
Nebraska
$14K – – –
AIP
42
Ameritas Investment Partners
Nebraska
$13K +$11.9K +435 New
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$12K -$29K -1,058 -73%
CCA
44
Catalyst Capital Advisors
New York
$7K – – –
SEI Investments
45
SEI Investments
Pennsylvania
$3K +$2.44K +89 New
AG
46
Advisor Group
Arizona
$3K +$2.74K +100 New
SFM
47
Sphera Funds Management
Israel
– -$1.9M -78,284 Closed
Norges Bank
48
Norges Bank
Norway
– -$425K -17,500 Closed
Millennium Management
49
Millennium Management
New York
– -$247K -10,182 Closed
LCM
50
Laurion Capital Management
New York
– -$243K -10,000 Closed
1
2
3

DOVA Hedge Fund Activity: Q4 2017 in Review

48 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Dova Pharmaceuticals, Inc. Common Stock (DOVA) for Q4 2017, worth a combined $209M — up 30% from $160M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new DOVA positions and 8 closed out — a net gain of 9 holders — while 17 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, adding an estimated $9.55M. The largest seller was Fidelity Investments, cutting an estimated $3.26M.

  • 48 institutional investors held Dova Pharmaceuticals, Inc. Common Stock (DOVA) as of Q4 2017, up from 39 in Q3 2017.
  • Funds reported $209M of Dova Pharmaceuticals, Inc. Common Stock stock for Q4 2017, up 30% quarter-over-quarter.
  • 17 funds opened new Dova Pharmaceuticals, Inc. Common Stock positions in Q4 2017 and 8 closed out, a net change of +9 holders.
  • The largest Dova Pharmaceuticals, Inc. Common Stock buyer in Q4 2017 was BlackRock, an estimated $9.55M added.
  • The largest Dova Pharmaceuticals, Inc. Common Stock seller in Q4 2017 was Fidelity Investments, an estimated $3.26M sold.

Based on aggregated 13F filings for Q4 2017.